FDA Adverse Event Death Summary report: N

WALLSTENT BILIARY ENDOPROSTHESIS

MDR report key: 2180064 · Received July 27, 2011

Report

Report Number
3005099803-2011-02561
Event Type
Death
Date Received
July 27, 2011
Date of Event
May 19, 2011
Report Date
July 5, 2011
Manufacturer
BOSTON SCIENTIFIC - GALWAY
Product Code
FGE
PMA / PMN Number
K000308
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SE
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

(B)(4) - STENT BLOCKED/OCCLUDED. THE COMPLAINANT INDICATED THAT THE DEVICE REMAINS IMPLANTED AND WILL NOT BE RETURNED FOR EVALUATION; THEREFORE, A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. IF ANY FURTHER RELEVANT INFORMATION IS IDENTIFIED, A SUPPLEMENTAL MEDWATCH WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A WALLSTENT BILIARY ENDOPROSTHESIS WAS USED DURING AN ERCP (ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY) PROCEDURE UNDER SEDATION IN THE COMMON BILE DUCT, PERFORMED ON (B)(6) 2010. ACCORDING TO THE COMPLAINANT, THERE WERE NO PROBLEMS REPORTED DURING THE INITIAL STENT PLACEMENT, WHICH WAS PLACED FOR ALLEVIATION OF SYMPTOMS FROM A NON-RESECTABLE MALIGNANT BILIARY STRICTURE. ON (B)(6) 2011 THE PATIENT WAS ADMITTED TO THE HOSPITAL FOR OBSERVATION AND WAS REPORTED IN VERY POOR GENERAL CONDITION. THE PATIENT HAD JAUNDICE AND AN ELEVATED BILIRUBIN LEVEL OF 310, INDICATING INSUFFICIENT BILIARY DRAINAGE. THIS WAS CLASSIFIED AS STENT FAILURE. NO INTERVENTION WAS PERFORMED, AND THE PATIENT DIED ON (B)(6) 2011. THE PHYSICIAN REPORTED THE CAUSE OF DEATH AS CANCER DISEASE PROGRESSION. NO AUTOPSY WAS PERFORMED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 WALLSTENT BILIARY ENDOPROSTHESIS CATHETER, BILIARY, DIAGNOSTIC FGE BOSTON SCIENTIFIC - GALWAY H965431100 0013406385

Patients

Seq Age Sex Outcome Treatment
1 88 YR Death| H